NTLA Jan 2025 22.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:59PM EDT. Market open.
| Previous Close | 4.7300 |
| Open | 4.7300 |
| Bid | 5.1000 |
| Ask | 5.7000 |
| Strike | 22.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 4.7300 - 4.7300 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 65 |
Simply Wall St.It Looks Like Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights Intellia Therapeutics will host its Annual General Meeting on 12th of June CEO John Leonard's total...
ZacksIntellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data
Intellia (NTLA) gains 10% after reporting encouraging long-term efficacy data from the phase I portion of its early to mid-stage study evaluating NTLA-2002 for treating hereditary angioedema.
Insider MonkeyIs Intellia Therapeutics, Inc. (NASDAQ:NTLA) the Most Promising Gene Therapy Stock to Buy Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Intellia Therapeutics, Inc. (NASDAQ:NTLA) is the most promising gene therapy stock to buy now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This […]
© 2024 Yahoo. All rights reserved.